Reaction

Breast Discharge reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,729 reports · 23 co-occurring drugs

As of the last recalculation, Breast Discharge appears in 1,729 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is PALIPERIDONE PALMITATE (PRR 43.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Paliperidone Palmitate10843.043.2
Paliperidone7942.742.8
Risperidone21722.322.4
Etonogestrel4611.911.9
Lurasidone Hydrochloride2011.611.6
Etonogestrel And Ethinyl Estradiol2111.511.5
Brexpiprazole1511.011.0
Levonorgestrel16510.810.8
Cariprazine79.19.1
Ribociclib238.98.9
Ziprasidone Mesylate108.58.5
Ziprasidone117.67.6
Atovaquone57.57.5
Atomoxetine Hydrochloride136.66.6
Drospirenone And Ethinyl Estradiol246.66.6
Interferon Beta-1B106.36.3
Medroxyprogesterone Acetate256.16.1
Ado-Trastuzumab Emtansine45.75.7
Cortisone Acetate54.94.9
Vortioxetine64.34.3
Asenapine Maleate34.24.2
Palbociclib243.13.1
Copper41.11.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.